Abstract
Introduction
Caveolae were initially discovered by electron microscopy more than 50 years ago and described as flask-shaped invaginations of the plasma membrane [1, 2] . Similar structures are found in a wide variety of differentiated cells, including adipocytes, pneumocytes, fibroblasts, smooth and striated muscle cells, as well as endothelial cells [3] . Caveolae 
have been considered to be a subgroup within the category of membrane microdomains referred to as lipid rafts that are enriched in lipids including cholesterol and sphingolipids (GM1, sphingomyelin and ceramide). The specific composition results in a higher degree of organization of the lipid constituents in these membrane microdomains, known as the liquid-ordered state, as well as the characteristic property of insolubility in non-ionic detergents at lower temperatures that permitted
biochemical characterization of such domains [4, 5] . In the past years, considerable controversy has arisen over what constitutes a lipid raft. However, it is beyond the scope of this review to discuss this aspect in sufficient detail. The interested reader may wish to consider additional references discussing related issues [6] [7] [8] .
Unlike lipid rafts, which represent planar, morphologically indistinguishable regions of the plasma membrane, caveolae are coated by a unique family of proteins, termed caveolins that oligomerize to generate large macromolecular complexes. In doing so, caveolins are thought to define caveolae architecture and morphology perceived by microscopy [9] [10] [11] [12] . Consistent with this view, caveolin concentration is high in caveolae molecules per caveolae) [13] and they have been proposed to [14] ). Alternatively, caveolae formation may require association of other proteins that are then stabilized in the presence of caveolins [15] . Here, it is important to emphasize the fact that caveolae morphology is not invariant. Depending on the cell type and the circumstances, caveolae also can be flattened out within the plane of the membrane or accumulate either individually or as multi-vesicular clusters beneath the plasma membrane [14, 16] .
The caveolins
The caveolin family is composed of the three isoforms in mammalian cells, caveolin-1, -2 and -3 [17] [18] [19] . Caveolin-1 is expressed in a variety of tissues. Caveolin-3, however, is more restricted in its distribution and has been described particularly in muscle [20] and also, more recently, in glial cells [21] .
Caveolin-2 is usually co-expressed with caveolin-1, but its function is less well understood. Caveolin-1 forms homo-dimers, as well as heterodimers with caveolin-2. These aggregate into oligomeric structures containing 14-16 molecules in the Golgi and then coalesce into large macromolecular complexes that define caveolae architecture at the plasma membrane or possibly before hand in the
Golgi (see discussion in [14] ). In caveolin-1 knockout mice, caveolae are only detectable in skeletal and heart muscle cells [9, 10] . In knockout mice for caveolin-2, no changes in caveolae number or morphology are detectable [22, 23] . Caveolin-3 knockout mice lack caveolae in skeletal and heart muscle [24] . Double knockout mice for caveolin-1 and -3 are completely devoid of caveolae [12] . [14, 25] [26, 27] .
Together with a large body of data available in the literature, these results corroborate the notion that either caveolin-1 or caveolin-3 is required to form caveolae. Caveolin-2 appears less important in this respect, although presence of this isoform does modulate efficiency of caveolae formation, as well as morphological traits of caveolae. Also other proteins appear important in this respect (see discussion in

). In particular, the cytosolic protein PTRFcavin, initially identified as a transcription factor, was recently shown to represent an abundant caveolar coat protein that is required for stabilization of the characteristic flask-shaped plasma membrane invaginations and probably mediates interactions of these structures with the cytoskeleton
Two variants of caveolin-1 have been described, caveolin-1␣ (residues and the 3 kD-smaller caveolin-1␤ (residues , which is either generated from full-length mRNA by alternative initiation or by transcription of a shorter splice variant [28] [29] [30] . Interestingly, the shorter caveolin-1␤ variant is mainly present in shallow caveolae and at the leading edge of migrating cells (see Table 1 [32] .
, [31]). Coincident with the possibility that caveolin-1␣ and -1␤ may fulfill distinct functions, different roles have been ascribed to the two in zebrafish development
Caveolin-1 was initially described as a prevalent target for tyrosine phosphorylation in Rous sarcoma virus transformed chicken fibroblasts [33] [34] [35] [14, 16] (Fig. 2) . The following paragraphs will focus on the discussion of such issues. Fig. 2 ).
Caveolin-1 distribution
Caveolin-1 and internalization
Caveolae are implicated in internalization via mechanisms that are distinct from those described for classic endocytosis [74] . Although several alternatives to clathrin-mediated endocytosis exist where caveolae or caveolae-like domains have been implicated, including potocytosis [75, 76] , transcytosis [77, 78] and internalization of microorganisms [79, 80] 
, the precise role of caveolin-1 in these events often remains controversial. For instance, caveolin-1 has been proposed to act in internalization in a manner akin to clathrin that recruits receptor molecules into coated pits and also drives membrane invagination in classic endocytosis.
Consistent with this type of analogy, caveolin-1 participates in the recruitment of src to cholesterol-rich microdomains required for dynamin-2 phosphorylation, activation and severing of caveolae from the plasma membrane [81] [82] [83] . However, more recent evidence indicates that caveolin-1(PY14), rather than the non-phosphorylated protein, is responsible for internalization of membrane microdomains and associated proteins downstream of integrins [84] . Likewise, the EGF receptor is internalized via caveolae to a perinuclear compartment following exposure to oxidative stress in a manner that requires src-dependent phosphorylation of caveolin-1 on tyrosine 14 [85] . Thus, while similarities exist, caveolinmediated internalization clearly differs from clathrin-dependent [18, 86, 87] . Second, unlike clathrin-coated endosomes, caveolae are essentially stable vesicular transporters that do not intermix [88] . Third [89] . For a more detailed discussion of the regulation of raft-dependent endocytic pathways and the role of caveolin-1 in these events, the interested reader is referred to a recent review [95] . [99, 100] . [102, 103] ). Taken together, these data underscore the importance of cholesterol-containing membrane microdomains as structures that are required to help molecules coalesce in a meaningful manner and thereby promote signalling (see discussion in [104, 105] ). However the relationship is complex and needs to be assessed on a case-by-case basis. A more detailed discussion of this topic is available elsewhere [80, 101] .
Fig. 1 Caveolin-1 is a highly versatile regulator of cell signaling. (A) At the molecular level, Caveolin-1 can modulate the flow of information through different cellular signaling pathways in distinct ways. Caveolin-1 acts as a scaffolding protein by binding to proteins involved in different signal transduction pathways. The caveolin-1 scaffolding domain (CSD) mediates interaction with and inhibition of protein tyrosine kinases (PTKs), G-coupled receptors (GCRs), elements of the MAPK/ERK pathway, members of the protein kinase C (PKC) family and nitric oxide synthases (NOS), in particular the endothelial isoform (eNOS). Additional mechanisms to CSD-mediated inhibition of target proteins that result in loss of target protein activity, include proteasome-mediated degradation as has been described for the inducible isoform of nitric oxide synthase (iNOS). Furthermore, inhibition of ␤-cateninTcf/Lef-dependent transcription of genes such as cyclin D1 and surviving by poorly characterized pathways has been observed. The general consequence of these interactions is that caveolin-1 presence is associated with inhibition of cell proliferation and/or survival. (B) Alternatively, however, caveolin-1 has been implicated as a positive element in insulin receptor (IR) signalling and coupling of the integrin signalling to the MAPK/ERK pathway via focal adhesion kinase (FAK) and src family kinases (SFKs). Such positive signalling downstream of caveolin-1 is frequently associated with phosphorylation on tyrosine 14, whereby downstream positive effectors include Csk, Grb7. Alternatively, however, positive signalling via fyn downstream of integrin receptors is not known to require caveolin-1 phosphorylation. Rather, phosphorylation on tyrosine 14 is implicated as a negative regulator of rac-1 in conjunction with integrin signalling (see text for details).
endocytosis. Additional aspects highlighting these differences are listed below. First, caveolin-1 interacts with many proteins at the plasma membrane via the CSD; however, this interaction is not necessarily what drives presence in the caveolae compartment, as is the case for the EGF receptor, the endothelial isoform of nitric oxide synthase (eNOS), src-family tyrosine kinases, G␣q and the insulin receptor
Caveolin-1 and cholesterol
Although disruption of microdomains by cholesterol sequestration generally blocks signalling via growth factor receptors (PDGF, insulin), such treatments have also been found to promote signalling, for instance, downstream of the EGF receptor in cells expressing caveolins (reviewed in [101]). In T-cells, which typical
Regulation of caveolin-1 expression
Analysis of patients identified a P132L mutation in caveolin-1 in about 16% of breast cancer samples analyzed [106] [108] . Despite such data and the fact that post-transcriptional mechanisms of caveolin-1 regulation exist [109] , the majority of evidence available suggests that caveolin-1 is an example of a nonclassical tumour suppressor protein whose expression is modulated by transcriptional silencing via epigenetic changes rather than by mutation [110] [111] [112] [113] [114] . The following paragraphs are dedicated to the discussion of mechanisms implicated in the control of caveolin-1 transcription (see Table 2 ).
The MAPK/ERK pathway has been extensively characterized as a negative regulator of caveolin-1 expression [115] . [120] ) and protein kinase C␣ (PKC␣, [120] ). Also, testosterone promotes transcription of the caveolin-1 gene via an androgen receptor-dependent mechanism [121] . Factors directly implicated in transcription of caveolin-1 include Foxo [122] , PPAR␥ [123] , p53 [124] , NF-B [125] and Sp1 [126] . Furthermore, the caveolin-1 promoter contains two SREBP-binding elements sensitive to cholesterol content and degree of oxidation [127] . Indeed, caveolin-1 expression is positively regulated by cholesterol, both by increasing mRNA levels and by stabilizing the protein [126] . Unlike the aforementioned transcription factors, c-myc, KLF11 and oestrogen-receptor ␣ suppress caveolin-1 expression [128] [129] [130] [131] . Also, oxysterols reduce caveolin-1 expression via a transcriptional mechanism [127] .
Thus Fig. 2 ). Segregation of the data available into mechanisms reported in 'non-transformed' versus 'cancer' cells does not yield additional insight in this respect (see Table 2 ). In addition, the recent finding that regulation of caveolin-1 expression downstream of ras differs dramatically between mouse and human cells [132] [134, 135] [6, 16, 50] , results from these studies helped to identify a large number of proteins and lipids associated with caveolae, many of which are involved in signal transduction [136] . In doing so, the experimental basis was generated supporting the 'signalosome' or 'caveolae signalling hypothesis', by which caveolae were suggested to play a central role in orchestrating signal transduction, and caveolin-1 was considered essential both to caveolae structure and function [3, 18, 53, 60] [138] . Thus, despite the relatively mild phenotypes detected, knockout mice do display physiologically significant deficiencies. Presumably, the conjunction of effects contributes to the reduced ability of these mice to respond to specific stress situations and, as a consequence, a significant reduction in lifespan is observed [9, 10, 139, 140] . [117] . Furthermore, caveolin-1 inhibits signalling via the ␤-catenin/Tcf-Lef pathway [143, 144] , promotes cell cycle arrest via a p53/p21 Waf1/Cip1 -dependent mechanism [145] and favours premature cell senescence [146, 147] . [18, 23] 
Caveolin-1 in signal transduction
As alluded to previously, caveolin-1 was first described as a highly phosphorylated protein on tyrosine in Rous sarcoma virus transformed chick fibroblasts and a component of caveolae [33-35, 133]. Thus, from the onset, presence and phosphorylation of caveolin-1 were associated with events involved in cell signalling and transformation. Since then a great deal of effort has been focused on characterizing the proteins associated with caveolin-1 and caveolae. In this respect, the observation that caveolin-1 is identical to VIP21, a major component of detergent-insoluble, non-coated pits
turned out to be particularly helpful. Since then, a plethora of purification schemes have been devised to isolate and characterize caveolae and raft components, a large number of which are based on procedures involving cell solubilization in non-ionic detergents at low temperature and subsequent flotation of the light buoyant, vesicle-associated components in a sucrose gradient. Although prone to many artefacts
Perhaps the clearest, generally accepted, exception in this respect is the endothelial isoform of nitric oxide synthase (eNOS). Caveolin-1 presence inhibits eNOS in vitro and in vivo, most likely via direct interaction, and in knockout mice eNOS activity is elevated and associated with vascular defects [9, 10]. Additional examples underscoring the role of caveolin-1 as a regulator of cell signalling do exist. For instance, caveolin-1 knockout mice display a premature lactation phenotype that is attributed to hyperactivation of the Jak2/STAT5a signalling pathway due to reduced Jak2 tyrosine kinase inhibition via interaction with caveolin-1 [137]. Moreover, increased activity of the MAPK/ERK signalling pathway is associated with neointimal hyperplasia, cardiac hypertrophy and increased sensitivity to carcinogens, while enhanced proliferation of intestinal crypts cells is linked to alterations in Wnt/␤-catenin signalling. A more extensive summary of connections between observed phenotypes and possible mechanisms is provided elsewhere
Following the isolation and characterization of caveolae, it quickly became apparent that caveolin-1 not only co-fractionated (and in some cases co-localized) with many signal transduction proteins, such as EGF receptor, PDGF receptor, insulin receptor,
Alternative mechanisms of caveolin-1-mediated control in signalling
The aforementioned view of caveolin-1-mediated control in signalling was based on observations linking binding to subsequent inhibition of target protein function. Most of the initial interactions described occurred via the CSD in caveolin-1 and the CBD found in the respective target protein (see text above,
Control of transcription
Work from a number of independent research groups has implicated caveolin-1 as a negative regulator of ␤-catenin-Tcf/Lefdependent transcription [143, 144, 154] . Association between caveolin-1 and ␤-catenin was initially observed in different cell systems [144] . Furthermore, caveolin-1 expression and intracellular distribution depend on cell-cell adhesion in a manner similar to ␤-catenin [116, 117] [154, 157] . The expression of E-cadherin is reportedly inhibited by ␤-catenin dependent mechanisms and by the repressor snail [158] [159] [160] . Consistent with the notion that caveolin-1 presence can promote E-cadherin expression, caveolin-1 inhibits ␤-catenin-mediated transcription as well as the expression of snail [154] . Interestingly, caveolin-1 also precludes EMT by promoting membrane localization of E-cadherin and stabilizing adherens junctions via inhibition of src [161] .
In this respect, it is worth noting that the regulation of ␤-catenin-dependent transcription by caveolin-1 is likely to be relevant in human cancers, especially those where ␤-catenindependent transcription is altered, such as colon cancer ([162] ; see Fig. 2 ). Caveolin-1 expression is down-regulated both in colon tumour mucosa and stroma when compared to samples of normal tissue from the same patients. Furthermore, caveolin-1 levels were found to be extremely low in a number of different colon carcinoma cell lines and re-expression of caveolin-1 was sufficient to block tumour formation of colon carcinoma cells in nude mice [50, 163] . Also, the re-expression of caveolin-1 in the breast cancer cell lines MCF7 and ZR75 is sufficient to reduce proliferation and promote apoptosis, possibly by a mechanism involving down-regulation of survivin [143] . Consistent with these observations, the absence of caveolin-1 in vivo in knockout mice leads to hyper-proliferation and enhanced ␤-catenin-Tcf/Lef signalling in both, intestinal crypts and mammary gland stem cells [164, 165] . [168] . Alternatively, however, phosphorylation at this site is considered to be a crucial event in integrin-regulated membrane microdomain internalization [84, 169] , as well as EGF-induced caveolae formation [40] . [144, 155] .
Other modes of control
Cell proliferation
Earlier work by Lisanti and collaborators showed that caveolin-1 modulated the expression of cyclin D1 via a transcriptional mechanism involving the Wnt-␤-catenin-Tcf/Lef
Subsequent studies in fibroblasts indicated that expression of caveolin-1 inhibited cell proliferation by arresting cells in the G0/G1 phase of the cell cycle and decreasing the S phase population. These changes were mediated by a mechanism dependent on p53/p21
WAF1/CIP1 [145] . [170] . Although initial data restricted caveolin-1-mediated control of the cell cycle to the G0/G1 and S phases, more recent evidence indicates that caveolin-1 expression also reduces the number of cells in G2/M while augmenting the sub G0/G1, apoptotic population. These alterations were associated with changes in survivin, rather than cyclin D1 expression [143] . In support of the notion that caveolin-1 modulates passage through the G2/M checkpoint, the chemotherapeutic drug, taxol, was shown to induce caveolin-1 accumulation and G2/M arrest in A549 lung cancer cells before these cells commit to cell death [171] .
In summary, both inhibition of cyclin D1 and survivin expression reduce cell proliferation. The extent to which one or the other of these two mechanisms is operational downstream of caveolin-1 appears to depend on the cellular context [143] . This conclusion is further sustained by the fact that caveolin-1 presence is also associated with enhanced cell cycle progression in hormonedependent breast cancer cells stimulated with a progesterone analogue [42] . The precise mechanisms that explain such differential responsiveness to caveolin-1 presence remain to be defined (see Fig. 1 ). [174, 175] . Caveolin-1-mediated activation of Akt was associated with reduced ceramide synthesis [175] . This observation is controversial, given that caveolin-1 reportedly promotes ceramide-mediated cell death via inhibition of the PI3K/Akt pathway [176] . Furthermore, cells lacking endogenous caveolin-1 are resistant to apoptosis and, in this case, inhibition of the PI3K/Akt pathway promotes apoptosis [119] .
Cell death and apoptosis
Although apoptosis appears to be the predominant mode of cell death promoted by caveolin-1 presence, the mechanisms underlying these events are still not well defined. Caveolin-1 has been shown to promote caspase-3 activation [119] and data from our laboratory implicated caspase-9, but not caspase-8, as assessed by caspase-9 cleavage and selective inhibition of apoptosis using z-LEHD-fmk (Torres and Quest, unpublished data) . Also caveolin-1 tyrosine phosphorylation was recently shown to sensitize MCF7 breast cancer cells to paclitaxel-induced apoptosis by inactivating Bcl2 and increasing mitochondrial permeability [177] . Taken together, these results suggest that caveolin-1 promotes activation of the intrinsic cell death pathway. Indeed, cell cycle changes and apoptosis induced by caveolin-1 expression are prevented by ectopic expression of survivin [143] as might be expected given that survivin inhibits the intrinsic apoptosis pathway and 'default' apoptosis at the G2/M checkpoint of the cell cycle [178] . [141] and re-expression of caveolin-1 was sufficient to revert the transformed phenotype and prevent anchorage independent growth of these cells [142] . In addition, caveolin-1 down-regulation using antisense oligos is sufficient to drive NIH3T3 cell transformation [117] . These results indicate that loss of caveolin-1 is necessary and sufficient to promote cell transformation, at least in some cell lines, supporting the notion that it functions as a tumour suppressor [18, 60] . Indeed, caveolin-1 expression is reduced in several human tumours, including lung [66, 180, 181] , mammary [182] , colon [50, 163] and ovarian carcinomas [183] and sarcomas [184] , as well as osteosarcomas [185] and re-expression of caveolin-1 often, but not always (see [121, [186] [187] [188] [189] [190] [9, 10, 118, [191] [192] [193] [121] and caveolin-1 presence promotes tumour growth [186] and metastasis of prostate cancer cells via an autocrine/paracrine mechanism [188, 189] . In patients, caveolin-1 presence is associated with angiogenesis, aggressive cancer recurrence, elevated metastasis of prostate tumours and poorer patient prognosis [121, 187, 190] .
Caveolin-1 in cancer
One might argue that such aberrant behaviour of caveolin-1 in the case of prostate (and T cell leukaemia cell lines, see [195] [196, 197] and caveolin-1 expression in these cells promotes anchorage-independent survival by preventing anoikis [198, 199] . In breast carcinomas, caveolin-1 overexpression has also been associated with metastasis and poor patient prognosis [200] . Likewise, others detected caveolin-1 in myoepithelial cells, endothelial cells and a subset of fibroblasts, but not in luminal epithelial cells (see also [194] [201] . Similarly, in patients with non-small cell lung cancer and esophageal squamous cell carcinoma increased expression of caveolin-1 correlates with poor patient prognosis [202, 203] . Fig. 2 ) may contribute to the pathogenesis of gastric cancer [204] .
Interestingly, caveolin-1 is associated with polarized distribution of cell signalling components and caveolin-1 is required for cell polarization and migration in two and three dimensions [148, 205, 206] [207] , as well as a mechanism involving src kinase and Rho GTPases [208] . Alternatively, however, overexpression of caveolin-1 in osteosarcomas abolishes the metastatic ability of these cells by reducing activity of c-src and c-met [185] .
In (Fig. 2) . A possible explanation for these discrepancies is that caveolin-1 functions as a tumour suppressor in systems where negative signalling events downstream of caveolin-1 prevail (Fig. 1A) . Alternatively, positive caveolin-1-mediated signalling is likely to be more important in those cases where presence of the protein is associated with more aggressive tumour behaviour (Fig. 1B) 
